Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMA by Night Study
NCT05563675Phase 4Completed
- Sponsor
- COPD360Net
- Start
- Jan 2023
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by COPD360Net. Primary endpoints: COPD-related hospitalization-requiring exacerbations at 12 months and All-cause mortality at 12 months. Started Jan 2023; status: completed.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05563675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05563675.